Gautam, A IMPRS From Molecules to Organisms, Max Planck Institute for Developmental Biology, Max Planck Society;
Singh, R., Gautam, A., Chandel, S., Sharma, V., Ghosh, A., Dey, D., et al. (2021). Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach. In Silico Pharmacology, 9(1): 27. doi:10.1007/s40203-021-00089-8.